Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other neoplasm 1

Conditions

Breast Neoplasms 2439Neoplasms 1845Carcinoma, Non-Small-Cell Lung 1615Prostatic Neoplasms 1315Colorectal Neoplasms 1149Lung Neoplasms 993Neoplasm Metastasis 838Multiple Myeloma 802Leukemia, Myeloid, Acute 778Ovarian Neoplasms 686Pancreatic Neoplasms 673Melanoma 669Squamous Cell Carcinoma of Head and Neck 592Carcinoma, Hepatocellular 571Recurrence 570Brain Neoplasms 531Glioblastoma 521Stomach Neoplasms 506Head and Neck Neoplasms 504Triple Negative Breast Neoplasms 474Lymphoma 463Uterine Cervical Neoplasms 457Carcinoma, Renal Cell 430Precursor Cell Lymphoblastic Leukemia-Lymphoma 421Lymphoma, Non-Hodgkin 392Endometrial Neoplasms 386Sarcoma 372Lymphoma, Follicular 358Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 356

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rare Malignant Neoplasm × 1 year × Clear all
NCT07307053 2025-12-29

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
600 enrolled
Other neoplasmOther solid neoplasm

Rare Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡